(Date:12/1/2008)...ics see problems with the agency,s goals, commitme...ealthDay News) -- Responding to criticism that it ... supply, the U.S. Food and Drug Administration rel...tect consumers. , Among the most important chan...etter relationships with state and local health de...
(Date:12/1/2008)...ANTA, Dec. 1, 2008 The Arthritis Foundation annou...ze for research in arthritis. The recipients, Dr. ... of Physicians and Dr. Michel Nussenzweig of Rocke...tinued research advancements in the cure and contr...ognized for his research in the development and fu...
(Date:12/1/2008)...INGTON, Dec. 1 /PRNewswire-USNewswire/ -- Americ...ase of a model state legislative resolution opposi...L urges state legislatures to adopt the resolution.... , , Dr. Charmaine Yoest, AUL President &a...t, endangers women,s health. It protects and prom...
(Date:12/1/2008)...cription meds, supplements can also trigger acute ...c. 1 (HealthDay News) -- Antibiotics are the singl...drug-induced liver injury (DILI), researchers say....of cases of acute liver failure in the United Stat...e liver failure. , DILI is caused by a wide ran...
Breaking Medicine News(10 mins):Health News:FDA Touts Efforts to Enhance Food Safety 2Health News:FDA Touts Efforts to Enhance Food Safety 3Health News:FDA Touts Efforts to Enhance Food Safety 4Health News:Americans United for Life Urges State Legislatures to Oppose Federal Power Grab: Provides Model Resolution Denouncing Freedom of Choice Act (FOCA) 2Health News:Antibiotics Largest Cause of Drug-Induced Liver Damage 2...chiatrist Alois Alzheimer formally described chara...h ultimately came to bear his name. While internat...nd develop treatments have progressed significantl...lusive goal. A new research tool developed by Sus...
...the risk of dementia according to recent research....e a lower risk of dementia and Alzheimer’s disease...h oil is a key factor that is required for the pro...nervous system. These findings have been published...
...e risk of developing skin cancer is very high in l...one by researchers from Medical University of Graz...rnal. The study found out that marathon runners ha... and moles on their skin .Both liver spots and mol...
...killing abilities of existing cancer drugs? A prec...-AACR symposium on Molecular Targets and Cancer Th...at the answer is “yes.” These findings may lead to...ffering from non-small cell lung cancer (NSCLC), a...
Other Medicine News:Health News:Yeast Model Shows Promise as Alzheimer's Test 2Health News:Common Virus Enhances Cancer-Fighting Ability of Standard Chemotherapy Drugs 2(Date:11/26/2008)...nformation density, automation and intelligent cli...rasound to an all new level , , CHICAGO, Il...ealthcare ( www.siemens.com/healthcare ) highlig...canner (ABVS)(1), the world,s first multi-use, au...th Scientific Assembly and Annual Meeting of the R...
(Date:11/25/2008)... Ky., Nov. 25 Kleinert ...performed the fifth U.S. hand transplant on Messin...sville,s Jewish Hospital Hand Care Center on Monda...ound noon and was completed shortly after 9 p.m. i.../www.newscom.com/cgi-bin/prnh/20081125/DC48555-a )...
(Date:11/25/2008)...RANCISCO, Calif., Nov. 25 /PRNewswire-FirstCall/ -..., a biopharmaceutical company focused on,innovati...l be exploring,strategic alternatives for its pre...Company to focus its resources on the clinical dev...e, and to support the initial commercialization of...
(Date:11/25/2008)...Nov. 25 CardioVascular,...announced today that it has,dosed the first patie...e II,clinical trial to treat patients with severe...for the treatment of CORonary heart Disease) trial...ebo-controlled doses in approximately 120,patient...
Breaking Medicine Technology:Siemens Introduces New Standard of Care for Breast Ultrasound 2Siemens Introduces New Standard of Care for Breast Ultrasound 3Siemens Introduces New Standard of Care for Breast Ultrasound 4Siemens Introduces New Standard of Care for Breast Ultrasound 5Kleinert Kutz Hand Surgeons Perform Fifth U.S. Hand Transplant in Record Time at Jewish Hospital Hand Care Center 2Kleinert Kutz Hand Surgeons Perform Fifth U.S. Hand Transplant in Record Time at Jewish Hospital Hand Care Center 3Poniard Pharmaceuticals Announces Management Changes and Focus on Development and Commercialization of Picoplatin 2Poniard Pharmaceuticals Announces Management Changes and Focus on Development and Commercialization of Picoplatin 3CVBT Doses First Patient in its Phase II Clinical Trial for Severe Coronary Heart Disease 2CVBT Doses First Patient in its Phase II Clinical Trial for Severe Coronary Heart Disease 3Family history of alcoholism affects response to drug used to treat heavy drinking 1563 1Family history of alcoholism affects response to drug used to treat heavy drinking 1563 2UNCCD recognizes importance of satellites for combating desertification 453 1UNCCD recognizes importance of satellites for combating desertification 453 2New research shows ACTOS is associated with a 38 percent lower risk of heart attack 1559 1New research shows ACTOS is associated with a 38 percent lower risk of heart attack 1559 2Few Americans Know of Leg Artery Danger 1556 1Few Americans Know of Leg Artery Danger 1556 2Few Americans Know of Leg Artery Danger 1556 3...-Jul 10, 2007 - Corgenix Medical,Corporation (OTC ...,reported new clinical data demonstrating a signif...any,s patented AtherOx(TM),bio-markers and cardiov...st Congress of the International Society on Thromb..., Data released this week shows the association of...
... 2007 /PRNewswire/ -- Portola,Pharmaceuticals, Inc...pound, PRT054021, an oral Factor Xa inhibitor, tod...y on Thrombosis and Haemostasis,(ISTH) in Geneva, ...1 was safe, effective, and well tolerated for the,...n patients,undergoing total knee replacement (TKR)...
Other Medicine Technology:Corgenix Reports New Clinical Data Correlating AtherOx Technology,With Vascular Disease 2Corgenix Reports New Clinical Data Correlating AtherOx Technology,With Vascular Disease 3Corgenix Reports New Clinical Data Correlating AtherOx Technology,With Vascular Disease 4Portola Pharmaceuticals Announces Positive Data from a Phase II,Study of its Factor Xa Inhibitor at the XXI Congress of the,International Society on Thrombosis and Haemostasis 2Portola Pharmaceuticals Announces Positive Data from a Phase II,Study of its Factor Xa Inhibitor at the XXI Congress of the,International Society on Thrombosis and Haemostasis 3Portola Pharmaceuticals Announces Positive Data from a Phase II,Study of its Factor Xa Inhibitor at the XXI Congress of the,International Society on Thrombosis and Haemostasis 4... a national reference laboratory and a worldwide l...pment. ARUP offers an extensive test menu of highl... anatomic pathology. Owned by the University of Ut...alf of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide l...pment. ARUP offers an extensive test menu of highl... anatomic pathology. Owned by the University of Ut...alf of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide l...pment. ARUP offers an extensive test menu of highl... anatomic pathology. Owned by the University of Ut...alf of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide l...pment. ARUP offers an extensive test menu of highl... anatomic pathology. Owned by the University of Ut...alf of the nation's university teaching hospitals ...
Medicine Products: